Comparison of flow cytometry and next‐generation sequencing in minimal residual disease monitoring of acute myeloid leukemia: One institute’s practical clinical experience

Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1 ‐mutated acute myeloid leukaemia

(2021) Sanam Loghavi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia

(2020) Robert P. Hasserjian et al.   BLOOD

Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations

(2019) Evgenii Shumilov et al.   HEMATOLOGICAL ONCOLOGY

Next generation sequencing in diagnosis and MRD assessment of AML

(2019) Ross L. Levine et al.   HAEMATOLOGICA

Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies

(2019) Ricardo Sánchez et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Flow Cytometric, Morphologic, and Laboratory Comparative Study in Patients With Leukocytosis and Cytopenia

(2019) Estafani Rivas et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

(2018) Gerrit J. Schuurhuis et al.   BLOOD

Molecular Minimal Residual Disease in Acute Myeloid Leukemia

(2018) Mojca Jongen-Lavrencic et al.   NEW ENGLAND JOURNAL OF MEDICINE

The emerging role of measurable residual disease detection in AML in morphologic remission

(2018) F. Buccisano et al.   SEMINARS IN HEMATOLOGY

Assessment of Minimal Residual Disease in Standard-Risk AML

(2016) Adam Ivey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genomic Classification and Prognosis in Acute Myeloid Leukemia

(2016) Elli Papaemmanuil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Germ line mutations associated with leukemias

(2016) C. C. Porter   Hematology-American Society of Hematology Education Program

The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia

(2015) Juan Ouyang et al.   AMERICAN JOURNAL OF HEMATOLOGY

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia

(2015) Jeffery M. Klco et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Multi-color flow cytometric immunophenotyping for detection of minimal residual disease in AML: past, present and future

(2014) J M Jaso et al.   BONE MARROW TRANSPLANTATION

Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings

(2014) W. Cui et al.   International Journal of Laboratory Hematology

Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia

(2013) J. Kronke et al.   BLOOD

Identification of emergingFLT3ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin

(2013) Tiziana Ottone et al.   BRITISH JOURNAL OF HAEMATOLOGY

Tumor heterogeneity makes AML a “moving target” for detection of residual disease

(2013) W. Zeijlemaker et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY